The consensus price target hints at a 25.3% upside potential for Boston Scientific (BSX). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings ...
The consensus price target hints at a 33.6% upside potential for Simulations Plus (SLP). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings ...
Western Midstream grows assets, strengthens financials, expands projects, boosts cash flow and supports high yield. Learn why ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback